8-K filing — Simulations Plus, Inc. (SLP)
Filed: 2026-08-13 AccNo: 0001023459-26-000054 Size: 1 MB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Read original at edgarStocks · News reference
Simulations Plus Clears HSR Waiting Period For Altaris Acquisition, Closing Expected In H2 2026
Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus" or the "Company"), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, announced the
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 13, 2026, 9:02 PM
- Checked
- Aug 13, 2026, 9:02 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Dow Gains 50 Points; Simulations Plus Earnings Top Views
Dow Jones up 0.1% on Friday with NASDAQ and S&P 500 also rising. Communication services shares jumped 0.9% while health care fell 0.5%. Simulations Plus Inc beats earnings estimates, WD-40 Co and Jiuzi Holdings Inc see gains, eLong Power Holding Ltd and Virax Biolabs Group Ltd see losses. European shares mixed, Asian markets close mixed.
Read original at benzingaHalper Sadeh LLC is Investigating Whether SLP, HUN, OLN, PULM are Obtaining Fair Deals for their Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating four companies for potential securities law violations and breaches of fiduciary duties related to proposed mergers and acquisitions. The investigations concern whether shareholders are receiving fair consideration in these transactions, with concerns that insiders may benefit disproportionately and deal terms may prevent superior competing offers.
Read original at globenewswire-inc